SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?

Simone Dalm; Joost Haeck; Gabriela Doeswijk; Erik de Blois; Marion Jong; Carolien van Deurzen

doi:10.2967/jnumed.116.189035

SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?

Simone Dalm
, Joost Haeck
, Gabriela Doeswijk
, Erik de Blois
, Marion Jong
, Carolien van Deurzen

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1609-1614
Number of pages	6
Journal	Journal of Nuclear Medicine
Volume	58
Issue number	10
DOIs	https://doi.org/10.2967/jnumed.116.189035
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-01-40-01

Access to Document

10.2967/jnumed.116.189035

http://hdl.handle.net/1765/102341

Cite this

@article{9e2878cfd7d947159105fd28d6d3d1e1,

title = "SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?",

author = "Simone Dalm and Joost Haeck and Gabriela Doeswijk and \{de Blois\}, Erik and Marion Jong and \{van Deurzen\}, Carolien",

year = "2017",

doi = "10.2967/jnumed.116.189035",

language = "Undefined/Unknown",

volume = "58",

pages = "1609--1614",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",